[{"address1": "1776 Yorktown", "address2": "Suite 550", "city": "Houston", "state": "TX", "zip": "77056", "country": "United States", "phone": "832 260 0222", "website": "https://www.nexalin.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Ms. Marilyn  Elson", "age": 70, "title": "Controller", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 382720, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  White", "age": 61, "title": "President, CEO, CFO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 191292, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Patrick Claude", "title": "Co-Founder and Director of Engineering & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Owens M.D.", "age": 62, "title": "Chief Medical Officer & Director", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Nketiah", "age": 47, "title": "Senior Vice-President of Quality, Regulatory & Clinical Affairs", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 251603, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.42, "open": 1.38, "dayLow": 1.35, "dayHigh": 1.46, "regularMarketPreviousClose": 1.42, "regularMarketOpen": 1.38, "regularMarketDayLow": 1.35, "regularMarketDayHigh": 1.46, "volume": 53141, "regularMarketVolume": 53141, "averageVolume": 823156, "averageVolume10days": 241070, "averageDailyVolume10Day": 241070, "bid": 1.35, "ask": 1.43, "bidSize": 100, "askSize": 100, "marketCap": 10299636, "fiftyTwoWeekLow": 0.253, "fiftyTwoWeekHigh": 3.4, "priceToSalesTrailing12Months": 93.00065, "fiftyDayAverage": 1.02908, "twoHundredDayAverage": 0.596085, "currency": "USD", "enterpriseValue": 7355668, "floatShares": 5893178, "sharesOutstanding": 7436560, "sharesShort": 327190, "sharesShortPriorMonth": 160491, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.044, "heldPercentInsiders": 0.2292, "heldPercentInstitutions": 0.0064499998, "shortRatio": 0.22, "shortPercentOfFloat": 0.0554, "impliedSharesOutstanding": 8510150, "bookValue": 0.431, "priceToBook": 3.213457, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -4648709, "trailingEps": -0.63, "enterpriseToRevenue": 66.418, "enterpriseToEbitda": -1.292, "52WeekChange": 0.68902445, "SandP52WeekChange": 0.21080327, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NXL", "underlyingSymbol": "NXL", "shortName": "Nexalin Technology, Inc.", "longName": "Nexalin Technology, Inc.", "firstTradeDateEpochUtc": 1663335000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "89a9bd26-da35-3349-b37a-a80d55d9b163", "messageBoardId": "finmb_1763227626", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.385, "recommendationKey": "none", "totalCash": 2948433, "totalCashPerShare": 0.396, "ebitda": -5692042, "totalDebt": 4463, "quickRatio": 6.955, "currentRatio": 8.065, "totalRevenue": 110748, "debtToEquity": 0.139, "revenuePerShare": 0.015, "returnOnAssets": -0.64356005, "returnOnEquity": -1.07047, "freeCashflow": -2103410, "operatingCashflow": -3835384, "revenueGrowth": -0.466, "grossMargins": 0.76805, "operatingMargins": -79.10367, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-26"}]